{
  "DOI": "10.1038/ejhg.2008.37",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2008.37",
  "alternative-id": [
    "BFejhg200837"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Soini",
      "given": "Sirpa",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "the members of the Public and Professional Policy Committee (PPPC) and Patenting and Licensing Committee (PLC), on behalf of the ESHG",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Aymé",
      "given": "Ségolène",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Matthijs",
      "given": "Gert",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2008,
        4,
        24
      ]
    ],
    "date-time": "2008-04-24T11:53:32Z",
    "timestamp": 1209038012000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:56:37Z",
    "timestamp": 1684428997000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        5
      ]
    ],
    "date-time": "2023-10-05T09:06:53Z",
    "timestamp": 1696496813044
  },
  "is-referenced-by-count": 23,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "S1",
  "issued": {
    "date-parts": [
      [
        2008,
        4,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "S1",
    "published-print": {
      "date-parts": [
        [
          2008,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2008,
            4,
            24
          ]
        ],
        "date-time": "2008-04-24T00:00:00Z",
        "timestamp": 1208995200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg200837.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200837",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200837.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "S10-S50",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2008,
        4,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2008,
        4,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1126/science.1120014",
      "author": "K Jensen",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "issue": "5746",
      "journal-title": "Science",
      "key": "BFejhg200837_CR1",
      "unstructured": "Jensen K, Murray F : Intellectual property. Enhanced: intellectual property landscape of the human genome. Science 2005; 310 (5746): 239–240.",
      "volume": "310",
      "year": "2005"
    },
    {
      "key": "BFejhg200837_CR2",
      "unstructured": "Ibarreta D, Bock A-K, Klein C, Rodriguez Cerezo E : Towards quality assurance and harmonisation of genetic testing services in the EU; IPTS – Institute of Prospective Technological Studies, Publ. EUR 20977 2003."
    },
    {
      "key": "BFejhg200837_CR3",
      "unstructured": "National Academy of Sciences (NAS): Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation and Public Health. Washington, DC: National Academies Press, 2005 (\n                    http://www.nap.edu/catalog/11487.html\n                    \n                  )."
    },
    {
      "DOI": "10.1038/nbt0207-185",
      "author": "MM Hopkins",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Nat Biotech",
      "key": "BFejhg200837_CR4",
      "unstructured": "Hopkins MM, Mahdi S, Patel P, Thomas SM : DNA patenting: the end of an era? Nat Biotech 2007; 25: 185–187.",
      "volume": "25",
      "year": "2007"
    },
    {
      "key": "BFejhg200837_CR5",
      "unstructured": "Nuffield Council on Bioethics: The ethics of patenting DNA, a discussion paper. Nuffield Council on Bioethics 2002, (\n                    www.nuffieldbioethics.org\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR6",
      "unstructured": "International Bioethics Committee. Report of the IBC on Ethics, Intellectual Property and Genomics (Justice Michael Kurby, rapporteur), Paris 2002, (\n                    http://portal.unesco.org/shs/en/files/2139/10541304201FinalReportIP_en.pdf/FinalReportIP_en.pdf\n                    \n                  )."
    },
    {
      "DOI": "10.1038/nbt0906-1091",
      "author": "T Caulfield",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "journal-title": "Nature Biotech",
      "key": "BFejhg200837_CR7",
      "unstructured": "Caulfield T, Cook-Deegan RM, Kieff FS, Walsh JP : Evidence and anecdotes: an analysis of human gene patenting controversies. Nature Biotech 2006; 24: 1091–1094.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S1525-1578(10)60444-8",
      "author": "M Cho",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg200837_CR8",
      "unstructured": "Cho M, Illangasekare S, Weaver M, Leonard D, Merz J : Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3–8.",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1136/bmj.329.7479.1358",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "1358",
      "issue": "7479",
      "journal-title": "BMJ",
      "key": "BFejhg200837_CR9",
      "unstructured": "Matthijs G : Patenting genes. BMJ 2004; 329 (7479): 1358–1360.",
      "volume": "329",
      "year": "2004"
    },
    {
      "author": "AC Nunnally",
      "first-page": "209",
      "issue": "4",
      "journal-title": "Community Genet",
      "key": "BFejhg200837_CR10",
      "unstructured": "Nunnally AC, Webster CJ, Brown SA, Cohen GA : Genetic patent protection in the pharmaceutical and biotechnology industries. Community Genet 2005; 8 (4): 209–216.",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201503",
      "author": "B Verbeure",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "issue": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg200837_CR11",
      "unstructured": "Verbeure B, Matthijs G, Van Overwalle G : Analysing DNA patents in relation with diagnostic genetic testing. Eur J Hum Genet 2006; 14 (1): 26–33.",
      "volume": "14",
      "year": "2006"
    },
    {
      "key": "BFejhg200837_CR12",
      "unstructured": "Nielsen L, Hartling O : The challenge of mixing oil and water; in: The Ethics of Patenting Human Genes and Stem Cells. Conference Reports and summaries, the Danish Council of Ethics 2004."
    },
    {
      "key": "BFejhg200837_CR13",
      "unstructured": "Grubb PW : Patents for Chemicals, Pharmaceuticals and Biotechnology, 4th edn. Oxford: Oxford University Press, 2004, pp 165–166, p 272, p 478."
    },
    {
      "key": "BFejhg200837_CR14",
      "unstructured": "OECD: Guidelines for the licensing of genetic inventions. OECD Council 2006."
    },
    {
      "author": "CD Lopez-Beverage",
      "first-page": "35",
      "journal-title": "J Tech Law \u0026 Policy",
      "key": "BFejhg200837_CR15",
      "unstructured": "Lopez-Beverage CD : Should congress do something about upstream clogging caused by the deficient utility of expressed sequence tag patents? J Tech Law \u0026 Policy 2005; 10: 35–92.",
      "volume": "10",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng0605-557",
      "author": "Editorial",
      "doi-asserted-by": "publisher",
      "first-page": "557",
      "journal-title": "Nature Genet",
      "key": "BFejhg200837_CR16",
      "unstructured": "Editorial: Beyond genomics. Nature Genet 2005; 37: 557.",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nbt0307-273",
      "author": "C Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "273",
      "journal-title": "Nature Biotech",
      "key": "BFejhg200837_CR17",
      "unstructured": "Schmidt C : Negotiating the RNAi patent thicket. Nature Biotech 2007; 25: 273–275.",
      "volume": "25",
      "year": "2007"
    },
    {
      "key": "BFejhg200837_CR18",
      "unstructured": "Danish Council of Ethics: The ethics of patenting human genes and stem cells, conference reports and summaries. The Danish Council of Ethics, 2004."
    },
    {
      "author": "JF Merz",
      "first-page": "203",
      "issue": "4",
      "journal-title": "Community Genet",
      "key": "BFejhg200837_CR19",
      "unstructured": "Merz JF, Cho MK : What are gene patents and why are people worried about them? Community Genet 2005; 8 (4): 203–208.",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201111",
      "author": "B Godard",
      "doi-asserted-by": "publisher",
      "first-page": "S13",
      "issue": "Suppl 2",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg200837_CR20",
      "unstructured": "Godard B, Kääriäinen H, Kristoffersson U, Tranebjaerg L, Coviello D, Aymé S : Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet 2003; 11 (Suppl 2): S13–S48.",
      "volume": "11",
      "year": "2003"
    },
    {
      "key": "BFejhg200837_CR21",
      "unstructured": "UNESCO: International Declaration of Human Genetic Data, 2003."
    },
    {
      "author": "G Matthijs",
      "first-page": "27",
      "key": "BFejhg200837_CR22",
      "unstructured": "Matthijs G : DNA diagnostics in practice; in: Van Overwalle (eds): Gene Patents and Public Health. Brussels: Bruylant, 2007, pp 27–44.",
      "volume-title": "Gene Patents and Public Health",
      "year": "2007"
    },
    {
      "key": "BFejhg200837_CR23",
      "unstructured": "European Union Expert group (European commission): 25 recommendations on the ethical, legal and social implications of genetic testing, Brussels, 2004."
    },
    {
      "key": "BFejhg200837_CR24",
      "unstructured": "The Nuffield Trust: Genetics Scenario Project – Genetics and Health, 2000."
    },
    {
      "key": "BFejhg200837_CR25",
      "unstructured": "OECD: Quality Assurance and Proficiency Testing for Molecular Genetic Testing. Summary results of a survey of 18 OECD member countries. Paris: OECD, Biotechnology Division, 2005."
    },
    {
      "key": "BFejhg200837_CR26",
      "unstructured": "OECD: Genetic inventions, intellectual property rights and licensing practices: evidence and policies. OECD 2002."
    },
    {
      "DOI": "10.1038/nbt0407-388",
      "author": "ER Gold",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "Nature Biotech",
      "key": "BFejhg200837_CR27",
      "unstructured": "Gold ER, Bubela T, Miller AF, Nicol D, Piper T : Gene patents – more evidence needed, but policymakers must act. Nature Biotech 2007; 25: 388–389.",
      "volume": "25",
      "year": "2007"
    },
    {
      "author": "S Parthasarathy",
      "first-page": "235",
      "journal-title": "Community Genet",
      "key": "BFejhg200837_CR28",
      "unstructured": "Parthasarathy S : The patent is political: the consequences of patenting the BRCA genes in Britain. Community Genet 2005; 8: 235–242.",
      "volume": "8",
      "year": "2005"
    },
    {
      "key": "BFejhg200837_CR29",
      "unstructured": "Munktell P : Compulsory Patent Licensing, Master thesis, University of Lund, Sweden 2004."
    },
    {
      "DOI": "10.1007/s10689-005-2580-6",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Fam Cancer",
      "key": "BFejhg200837_CR30",
      "unstructured": "Matthijs G : The European opposition against the BRCA gene patents. Fam Cancer 2006; 5: 95–102.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1038/415577a",
      "author": "JF Merz",
      "doi-asserted-by": "publisher",
      "first-page": "577",
      "journal-title": "Nature",
      "key": "BFejhg200837_CR31",
      "unstructured": "Merz JF, Kriss AG, Leonard DG, Cho MK : Diagnostic testing fails the test. Nature 2002; 415: 577–579.",
      "volume": "415",
      "year": "2002"
    },
    {
      "author": "V Launis",
      "key": "BFejhg200837_CR32",
      "unstructured": "Launis V : Multidimensional Bioethics. A Pluralistic Approach to the Ethics of Modern Human Biotechnology. Turku: Painosalama Oy, 2001.",
      "volume-title": "Multidimensional Bioethics. A Pluralistic Approach to the Ethics of Modern Human Biotechnology",
      "year": "2001"
    },
    {
      "DOI": "10.1017/CBO9780511495342",
      "author": "G Laurie",
      "doi-asserted-by": "publisher",
      "first-page": "304",
      "key": "BFejhg200837_CR33",
      "unstructured": "Laurie G : Genetic Privacy, A Challenge to Medico-Legal Norms. Cambridge: Cambridge University Press, 2002, pp 304–307.",
      "volume-title": "Genetic Privacy, A Challenge to Medico-Legal Norms",
      "year": "2002"
    },
    {
      "key": "BFejhg200837_CR34",
      "unstructured": "Baldwin T : Problems in applying the patent system to human genes and possible solutions to these problems; in The Ethics of patenting human genes and stem cells. Conference Report and summaries, The Danish Council of Ethics 2004."
    },
    {
      "author": "D Beyleveld",
      "key": "BFejhg200837_CR35",
      "unstructured": "Beyleveld D, Brownsword R : Human Dignity in Bioethics and Biolaw, Ch 9. Oxford: Oxford University Press, 2001.",
      "volume-title": "Human Dignity in Bioethics and Biolaw, Ch 9",
      "year": "2001"
    },
    {
      "DOI": "10.1163/15718099720521896",
      "doi-asserted-by": "crossref",
      "key": "BFejhg200837_CR36",
      "unstructured": "Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo, 4.IV. 1997."
    },
    {
      "author": "J-C Galloux",
      "first-page": "370",
      "key": "BFejhg200837_CR37",
      "unstructured": "Galloux J-C : Patentability of the human genome; in Knoppers BM (ed): Human DNA: Law and Policy, International and Comparative Perspectives. Kluwer Law International: The Hague. 1997, p 370.",
      "volume-title": "Human DNA: Law and Policy, International and Comparative Perspectives",
      "year": "1997"
    },
    {
      "key": "BFejhg200837_CR38",
      "unstructured": "UNESCO: Universal Declaration on the Human Genome and Human Rights, 1997."
    },
    {
      "author": "D Beyleveld",
      "first-page": "157",
      "key": "BFejhg200837_CR39",
      "unstructured": "Beyleveld D, Brownsword R, Llewelyn M : The morality clauses of the directive on the legal protection of biotechnological inventions: conflict, compromise and the patent community; in Goldberg R, Lonbay J (eds): Pharmaceutical Medicine, Biotechnology, and European Law. Cambridge: Cambridge University Press, 2000, pp 157–181.",
      "volume-title": "Pharmaceutical Medicine, Biotechnology, and European Law",
      "year": "2000"
    },
    {
      "author": "D Beyleveld",
      "first-page": "57",
      "journal-title": "Med Law",
      "key": "BFejhg200837_CR40",
      "unstructured": "Beyleveld D : Law, ethics and research ethics committees. Med Law 2002; 21: 57–75.",
      "volume": "21",
      "year": "2002"
    },
    {
      "key": "BFejhg200837_CR41",
      "unstructured": "The European Group on Ethics in Science and New Technologies to the European Commission: Opinion No 16. Ethical aspects of patenting inventions involving human stem cells, May 7, 2002."
    },
    {
      "author": "G Van Overwalle",
      "first-page": "889",
      "journal-title": "International Review of Intellectual Property and Competition Law (IIC)",
      "key": "BFejhg200837_CR42",
      "unstructured": "Van Overwalle G : The implementation of the biotechnology directive in Belgium and its after effects. The introduction of a new research exemption and a compulsory license for public health. International Review of Intellectual Property and Competition Law (IIC) 2006; 37: 889–920.",
      "volume": "37",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nbt0805-929",
      "author": "J Bovenberg",
      "doi-asserted-by": "publisher",
      "first-page": "929",
      "journal-title": "Nature Biotech",
      "key": "BFejhg200837_CR43",
      "unstructured": "Bovenberg J : Whose tissue is it anyway? Nature Biotech 2005; 23: 929–933.",
      "volume": "23",
      "year": "2005"
    },
    {
      "key": "BFejhg200837_CR44",
      "unstructured": "UNESCO: Universal Declaration on Bioethics and Human Rights, 2005, (\n                    http://portal.unesco.org/shs/en/ev.php-URL_ID_1883\u0026URL_DO=DO_TOPIC\u0026URL_SECTION=201.html\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR45",
      "unstructured": "World Health Organisation (WHO): Review of Ethical Issues in Medical Genetics. Report of Consultants to WHO. Geneva: WHO, 2003."
    },
    {
      "key": "BFejhg200837_CR46",
      "unstructured": "Human Genome Organisation (HUGO). Bermuda Declaration, International Strategy Meeting on Human Genome Sequencing (Bermuda, 25th–28th February, 1996), 1996."
    },
    {
      "key": "BFejhg200837_CR47",
      "unstructured": "Human Genome Organisation (HUGO). Ethics Committee: Statement on Benefit sharing, 2000, (\n                    http://www.hugo-international.org/Statement_on_Benefit_Sharing.htm\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR48",
      "unstructured": "Human Genome Organisation (HUGO): Intellectual property committee: statement on patenting of DNA sequences in particular response to the European biotechnology directive, 2000. (\n                    http://www.hugo-international.org/committee_ip.htm\n                    \n                  )."
    },
    {
      "author": "JK Mason",
      "key": "BFejhg200837_CR49",
      "unstructured": "Mason JK, Laurie GT : Mason and McCall Smith's Law and Medical Ethics, 7th edn. Oxford: Oxford University Press, 2006.",
      "volume-title": "Mason and McCall Smith's Law and Medical Ethics",
      "year": "2006"
    },
    {
      "key": "BFejhg200837_CR50",
      "unstructured": "Nationaler Ethikrat (German National Ethics Council): The patenting of biotechnological inventions involving the use of biological material of human origin. Opinion. Nationaler Ethikrat, 2005."
    },
    {
      "key": "BFejhg200837_CR51",
      "unstructured": "Fahre Holt C : The Norwegian Board of Ethics; in The Ethics of patenting human genes and stem cells. Conference report and summaries, The Danish Council of Ethics, 2004."
    },
    {
      "key": "BFejhg200837_CR52",
      "unstructured": "Trilateral Project WM4: Report on Comparative Study in New Technologies (biotechnology, business methods, etc.). Theme: comparative study on ‘protein 3-dimensional (3-D) structure related claims’. European Patent Office, Japan Patent Office and United States Patent and Trademark Office. Vienna, 2002, (\n                    www.trilateral.net\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR53",
      "unstructured": "Human Genome Organisation (HUGO): Intellectual Property Committee: statement on the scope of gene patents research exemption, and licensing of patented gene sequences for diagnostics, 2003, (\n                    http://www.hugo-international.org/committee_ip.htm\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR54",
      "unstructured": "Nagaoka S, Aoki R : Economics of Research Exemption, Institute of Innovation Research Working Paper WP#06-04. Hitotsubashi University IIR, 2006."
    },
    {
      "key": "BFejhg200837_CR55",
      "unstructured": "Trilateral Project B3B: Report on Comparative Study on biotechnology patent practices. Theme: Comparative study on ‘reach-through claims’. European Patent Office, Japan Patent Office and United States Patent and Trademark Office. San Francisco 2001, (\n                    www.trilateral.net\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR56",
      "unstructured": "Gold ER, Joly Y, Caulfield T : Genetic Research Tools, the Research Exception and Open Science. GenEdit 2005, Vol. III, No. 2."
    },
    {
      "DOI": "10.1093/nar/gkj130",
      "author": "G Cochrane",
      "doi-asserted-by": "publisher",
      "first-page": "D10",
      "journal-title": "Nucl Acids Res",
      "key": "BFejhg200837_CR57",
      "unstructured": "Cochrane G, Aldebert P, Althorpe N, Andersson M, Baker W, Baldwin A : EMBL Nucleotide Sequence Database: developments in 2005. Nucl Acids Res 2006; 34: D10–D15.",
      "volume": "34",
      "year": "2006"
    },
    {
      "DOI": "10.1126/science.280.5364.698",
      "author": "MA Heller",
      "doi-asserted-by": "publisher",
      "first-page": "698",
      "issue": "5364",
      "journal-title": "Science",
      "key": "BFejhg200837_CR58",
      "unstructured": "Heller MA, Eisenberg RS : Can patents deter innovation? The anticommons in biomedical research. Science 1998; 280 (5364): 698–701.",
      "volume": "280",
      "year": "1998"
    },
    {
      "DOI": "10.1111/j.1748-720X.2003.tb00107.x",
      "author": "MR Henry",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "issue": "3",
      "journal-title": "J Law Med Ethics",
      "key": "BFejhg200837_CR59",
      "unstructured": "Henry MR, Cho MK, Weaver MA, Merz JF : A pilot survey on the licensing of DNA inventions. J Law Med Ethics 2003; 31 (3): 442–449.",
      "volume": "31",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrg1765",
      "author": "G Van Overwalle",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Nature Rev Genet",
      "key": "BFejhg200837_CR60",
      "unstructured": "Van Overwalle G, Van Zimmeren E, Verbeure B, Matthijs G : Models for facilitating access to patents on genetic inventions. Nature Rev Genet 2006; 7: 143–148.",
      "volume": "7",
      "year": "2006"
    },
    {
      "key": "BFejhg200837_CR61",
      "unstructured": "Teknologi-Rådet (The Danish Board of Technology): Recommendations for a Patent System of the Future. Reports 2005/7, 2005, (\n                    www.tekno.dk\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR62",
      "unstructured": "OECD: Research Use of Patented Knowledge. STI Working Paper 2006/2 by Chris Dent, Pauls Jensen, Sophie Waller and Beth Webster. OECD, 2006."
    },
    {
      "author": "P Rott",
      "first-page": "284",
      "journal-title": "Intellectual Property Quarterly",
      "key": "BFejhg200837_CR63",
      "unstructured": "Rott P : The Doha Declaration – Good News for Public Health? Intellectual Property Quarterly 2003; 3: 284–311.",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.2471/BLT.06.030445",
      "author": "E Van Zimmeren",
      "doi-asserted-by": "publisher",
      "first-page": "352",
      "journal-title": "Bull World Health Organ",
      "key": "BFejhg200837_CR64",
      "unstructured": "Van Zimmeren E, Verbeure B, Matthijs G, Van Overwalle G : A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions? Bull World Health Organ 2006; 84: 352–359.",
      "volume": "84",
      "year": "2006"
    },
    {
      "key": "BFejhg200837_CR65",
      "unstructured": "Aoki R : ‘Access to Genetic Patents – Economist's View’, presentation slides, ‘Gene Patents and Clearing Houses Workshop’, Centre for Intellectual Property Rights, Katholieke Universiteit, Leuven, Belgium 8–10 June, 2006."
    },
    {
      "author": "DW Opderbeck",
      "first-page": "167",
      "journal-title": "Harv J Law Technol",
      "key": "BFejhg200837_CR66",
      "unstructured": "Opderbeck DW : The Penguin's Genome, or Coase and Open Source Biotechnology. Harv J Law Technol 2004; 18: 167–227.",
      "volume": "18",
      "year": "2004"
    },
    {
      "author": "TJ Ebersole",
      "first-page": "6",
      "journal-title": "Intellect Prop Technol Law J",
      "key": "BFejhg200837_CR67",
      "unstructured": "Ebersole TJ, Guthrie MC, Goldstein JA : Patent pools as a solution to the licensing problems of diagnostic genetics. Intellect Prop Technol Law J 2005; 17: 6–13.",
      "volume": "17",
      "year": "2005"
    },
    {
      "key": "BFejhg200837_CR68",
      "unstructured": "OECD: Intellectual property and competition policy in the biotechnology industry. Policy Brief. OECD Observer, June 2005."
    },
    {
      "key": "BFejhg200837_CR69",
      "unstructured": "Aoki R, Nagaoka S : ‘Coalition Formation for a Consortium Standard Through a Standard Body and a Patent Pool: Theory and Evidence from MPEG2, DVD and 3G. Institute of Innovation Research Working Paper WP#05-01, Hitotsubashi University, 2005."
    },
    {
      "key": "BFejhg200837_CR70",
      "unstructured": "Aoki R, Nagaoka S : ‘The Utility Standard and the Patentability of Intermediate Technology’, Hi-Stat Discussion Paper No.75, Institute of Economic Research, Hitotsubashi University, 2005."
    },
    {
      "key": "BFejhg200837_CR71",
      "unstructured": "Thumm N : Research and patenting in biotechnology, a survey in Switzerland. Editor: Swiss Federal Institute of Intellectual Property, Publ. No 1 (12.03) Bern, Switzerland 2003, pp 39–40."
    },
    {
      "key": "BFejhg200837_CR72",
      "unstructured": "Bostyn SJP : Patenting DNA sequences (polynucleotides) and scope of protection in the European Union: an evaluation. Background study for the European Commission within the framework of the Expert Group on Biotechnological Inventions, EUR 21112, 2004."
    },
    {
      "key": "BFejhg200837_CR73",
      "unstructured": "Statens Offentliga Utredningar (SOU). Oinskränkt produktskydd för patent på genteknikområdet. SOU 2006:70, Edita Sverige AB, Stockholm, 2006, p 38."
    },
    {
      "DOI": "10.2471/BLT.06.030296",
      "author": "G Dutfield",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "Bull World Health Organ",
      "key": "BFejhg200837_CR74",
      "unstructured": "Dutfield G : DNA patenting: implications for public health research. Bull World Health Organ 2006; 84: 388–394.",
      "volume": "84",
      "year": "2006"
    },
    {
      "DOI": "10.3395/reciis.v1i1.40en",
      "doi-asserted-by": "crossref",
      "key": "BFejhg200837_CR75",
      "unstructured": "Palombi L : TRIPS, bilateralism and patents: how they are failing both the developed and the developing world and what to do about it. Elect J Commun Inf Innov Health 2007; 1: No 1, 71–81."
    },
    {
      "author": "L Palombi",
      "first-page": "782",
      "journal-title": "Univ NSW Law J",
      "key": "BFejhg200837_CR76",
      "unstructured": "Palombi L : Patentable Subject Matter, TRIPS and the European Biotechnology Directive Australia and Patenting Human Genes. Univ NSW Law J 2003; 26: 782–792.",
      "volume": "26",
      "year": "2003"
    },
    {
      "DOI": "10.1515/jibl.2005.2.2.62",
      "author": "L Palombi",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "J Int Biotechnol Law",
      "key": "BFejhg200837_CR77",
      "unstructured": "Palombi L : The impact of TRIPS on the validity of the European Biotechnology Directive. J Int Biotechnol Law 2005; 2: 15–23.",
      "volume": "2",
      "year": "2005"
    },
    {
      "key": "BFejhg200837_CR78",
      "unstructured": "Patterson LA : Biotechnology policy, in policy-making in the European Union; in Wallace H, Wallace W (eds) 4th edn. Oxford: Oxford University Press, 2000."
    },
    {
      "key": "BFejhg200837_CR79",
      "unstructured": "European Union: Life Sciences and biotechnology—A Strategy for Europe. Communication from the Commission to the European parliament, the Council, the Economic and Social Committee and the Committee of the Regions. COM, 2002, 27."
    },
    {
      "key": "BFejhg200837_CR80",
      "unstructured": "Gibbons M, Wittrock B Science as a Commodity, Harlow, Longman, 1985."
    },
    {
      "author": "P Wheale",
      "key": "BFejhg200837_CR81",
      "unstructured": "Wheale P, McNally R : Genetic Engineering: Catastrophe or Utopia? New York: St. Martin's Press Inc., 1988.",
      "volume-title": "Genetic Engineering: Catastrophe or Utopia?",
      "year": "1988"
    },
    {
      "key": "BFejhg200837_CR82",
      "unstructured": "National Institute Of Health (NIH): Best practices for the licensing of genomic inventions. Final notice. NIH, 2005."
    },
    {
      "key": "BFejhg200837_CR83",
      "unstructured": "Westerlund L : Biotech patents. Equivalency and Exclusions under European and US Patent Law. Kluwer Law International, 2002, p 57."
    },
    {
      "key": "BFejhg200837_CR84",
      "unstructured": "Fay S, Landegren U, Boisseau P : Infrastructures in Genomics and Protemics; in: ‘Future Needs for Research Infrastructures in Biomedical Sciences’, Workshop report, organised by European Commission, DG Research, Dir B and Dir F Brussels, July 2005."
    },
    {
      "author": "F Lenzerini",
      "first-page": "334",
      "key": "BFejhg200837_CR85",
      "unstructured": "Lenzerini F : Biotechnology, Human Dignity and the Human Genome; in Francioini F, Scovazzi T (eds): Biotechnol Int Law. Oxford: Hart Publishing, 2006, p 334.",
      "volume-title": "Biotechnol Int Law",
      "year": "2006"
    },
    {
      "key": "BFejhg200837_CR86",
      "unstructured": "World Health Organization (WHO): Commission on Intellectual Property Rights, Innovation and Public Health: Report, 2006."
    },
    {
      "key": "BFejhg200837_CR87",
      "unstructured": "Williams JR, (ed): The WMA Medical Ethics Manual. The World Medical Association, 2005, p 72, (\n                    http://www.wma.net/e/ethicsunit/resources.htm\n                    \n                  )."
    },
    {
      "key": "BFejhg200837_CR88",
      "unstructured": "Zika E, Gurwitz D, Ibarreta D : Pharmacogenetics and pharmacogenomics: state-of-the-art and potential socio-economic impact in the EU. European Commission's Joint Research Center, the Institute for Prospective Technological Studies (IPTS), April 2006."
    },
    {
      "author": "RS Eisenberg",
      "key": "BFejhg200837_CR89",
      "unstructured": "Eisenberg RS : Genomic patents and product incentives; in Knoppers BM (ed): Human DNA: Law and Policy, International and Comparative Perspectives. Kluwer Law International: The Hague. 1997.",
      "volume-title": "Human DNA: Law and Policy, International and Comparative Perspectives",
      "year": "1997"
    },
    {
      "key": "BFejhg200837_CR90",
      "unstructured": "Human Genetics Commission: Public attitudes to human genetic information. 2001, (\n                    http://www.hgc.gov.uk/UploadDocs/DocPub/Document/morigeneticattitudes.pdf\n                    \n                  )."
    },
    {
      "DOI": "10.1016/j.infoecopol.2003.09.002",
      "author": "R Aoki",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Inf Econ Policy",
      "key": "BFejhg200837_CR91",
      "unstructured": "Aoki R, Small J : Compulsory licensing of technology and the essential facilities doctrine. Inf Econ Policy 2004; 16: 13–29.",
      "volume": "16",
      "year": "2004"
    },
    {
      "key": "BFejhg200837_CR92",
      "unstructured": "United Nations: 55/2 Millennium Declaration, 2000, (\n                    http://www.un.org/millenniumgoals/background.html\n                    \n                  , \n                    http://www.un.org/millennium/declaration/ares552e.pdf\n                    \n                  )."
    }
  ],
  "reference-count": 92,
  "references-count": 92,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg200837"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Patenting and licensing in genetic testing: ethical, legal and social issues"
  ],
  "type": "journal-article",
  "volume": "16"
}